Enteric-coated mycophenolate sodium in de novo and maintenance kidney-pancreas transplant recipients.

about

Efficacy and safety of enteric-coated mycophenolate sodium in patients with de novo and maintenance renal transplantation.

P2860

Q51150911-1B88823A-79F0-482B-9186-C02417EAC60C

P2860

Enteric-coated mycophenolate sodium in de novo and maintenance kidney-pancreas transplant recipients.

Item

http://www.wikidata.org/entity/Q44024686

description

2011 nî lūn-bûn

@nan

2011年の論文

@ja

2011年学术文章

@wuu

2011年学术文章

@zh-cn

2011年学术文章

@zh-hans

2011年学术文章

@zh-my

2011年学术文章

@zh-sg

2011年學術文章

@yue

2011年學術文章

@zh

2011年學術文章

@zh-hant

name

Enteric-coated mycophenolate s ...... ancreas transplant recipients.

@en

Enteric-coated mycophenolate s ...... ancreas transplant recipients.

@nl

type

Item

label

Enteric-coated mycophenolate s ...... ancreas transplant recipients.

@en

Enteric-coated mycophenolate s ...... ancreas transplant recipients.

@nl

prefLabel

Enteric-coated mycophenolate s ...... ancreas transplant recipients.

@en

Enteric-coated mycophenolate s ...... ancreas transplant recipients.

@nl

P1476

Enteric-coated mycophenolate s ...... ancreas transplant recipients.

@en

P2093

Amado Andrés

http://www.w3.org/2001/XMLSchema#string

Angel Álonso

http://www.w3.org/2001/XMLSchema#string

Constantino Fernández

http://www.w3.org/2001/XMLSchema#string

Epi-trasplante Study, MIDATA Kidney-Pancreas Sub-study Group

http://www.w3.org/2001/XMLSchema#string

Frederic Oppenheimer

http://www.w3.org/2001/XMLSchema#string

José M Morales

http://www.w3.org/2001/XMLSchema#string

María J Ricart

http://www.w3.org/2001/XMLSchema#string

P2860

Efficacy and safety of enteric-coated mycophenolate sodium in de novo renal transplant recipients: pooled data from three 12-month multicenter, open-label, prospective studies.

Effect of diabetes mellitus on mycophenolate sodium pharmacokinetics and inosine monophosphate dehydrogenase activity in stable kidney transplant recipients

Review of the immunosuppressant enteric-coated mycophenolate sodium.

Adverse drug reaction driven immunosuppressive drug manipulations: a single-center comparison of enteric-coated mycophenolate sodium vs. mycophenolate mofetil.

Impact of gastrointestinal-related side effects on mycophenolate mofetil dosing and potential therapeutic strategies.

Enteric-coated mycophenolate sodium: a review of its use in the prevention of renal transplant rejection.

Conversion from mycophenolate mofetil to enteric-coated mycophenolate sodium in renal transplant recipients with gastrointestinal tract disorders.

Efficacy and safety of enteric-coated mycophenolate sodium in renal transplant patients with diabetes mellitus: post hoc analyses from three clinical trials.

Quality of life in renal transplant recipients following conversion from mycophenolate mofetil to enteric-coated mycophenolate sodium.

Improvement in 3-month patient-reported gastrointestinal symptoms after conversion from mycophenolate mofetil to enteric-coated mycophenolate sodium in renal transplant patients.

P304

424-431

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/J.1399-0012.2011.01526.X

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2011-10-17T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

22003898

http://www.w3.org/2001/XMLSchema#string

P921

mycophenolate sodium

Aizkuņģa dziedzeris

Enteric-coated mycophenolate sodium in de novo and maintenance kidney-pancreas transplant recipients.

about

P2860

P2860

Enteric-coated mycophenolate sodium in de novo and maintenance kidney-pancreas transplant recipients.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P921

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P921